These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 29813121

  • 21. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B, Xie Z, Li B.
    Gene; 2019 Mar 20; 689():76-83. PubMed ID: 30552981
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Systematic review of CYFRA 21-1 as a prognostic indicator and its predictive correlation with clinicopathological features in Non-small Cell Lung Cancer: A meta-analysis.
    Yu Z, Zhang G, Yang M, Zhang S, Zhao B, Shen G, Chai Y.
    Oncotarget; 2017 Jan 17; 8(3):4043-4050. PubMed ID: 28008142
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nuclear factor kappa B expression in non-small cell lung cancer.
    Zhang L, Ludden CM, Cullen AJ, Tew KD, Branco de Barros AL, Townsend DM.
    Biomed Pharmacother; 2023 Nov 17; 167():115459. PubMed ID: 37716117
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cox-2 in non-small cell lung cancer: a meta-analysis.
    Jiang H, Wang J, Zhao W.
    Clin Chim Acta; 2013 Apr 18; 419():26-32. PubMed ID: 23384501
    [Abstract] [Full Text] [Related]

  • 34. Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
    Giopanou I, Lilis I, Papaleonidopoulos V, Marazioti A, Spella M, Vreka M, Papadaki H, Stathopoulos GT.
    PLoS One; 2015 Apr 18; 10(7):e0132527. PubMed ID: 26147201
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
    Wang Q, Xu L, Wang G, Chen L, Li C, Jiang X, Gao H, Yang B, Tian W.
    PLoS One; 2020 Apr 18; 15(11):e0241241. PubMed ID: 33186371
    [Abstract] [Full Text] [Related]

  • 37. NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation.
    Dimitrakopoulos FI, Antonacopoulou AG, Kottorou A, Vlotinou H, Panagopoulos ND, Dougenis D, Scopa C, Papadaki H, Kalofonos HP.
    Virchows Arch; 2012 May 18; 460(5):515-23. PubMed ID: 22562129
    [Abstract] [Full Text] [Related]

  • 38. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Fan W, Yang H, Xue H, Sun Y, Zhang J.
    Int J Clin Exp Pathol; 2015 May 18; 8(5):5503-8. PubMed ID: 26191257
    [Abstract] [Full Text] [Related]

  • 39. The association of melanoma-associated antigen-A gene expression with clinicopathological characteristics and prognosis in resected non-small-cell lung cancer: a meta-analysis.
    Wang Y, Lu Y, Li J, Wu Y, Che G.
    Interact Cardiovasc Thorac Surg; 2019 Dec 01; 29(6):855-860. PubMed ID: 31384932
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.